Cargando…

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1

Ovarian cancer is among the leading cause of cancer-related deaths in females. In this study, we demonstrated that miR-595 expression was downregulated in the ovarian cancer tissues and cell lines. miR-595 expression was lower in the lymph node metastases tissues than in the primary ovarian cancer t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Songyu, Zhang, Mingyue, Chen, Xiuwei, Liu, Yunduo, Lou, Ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349973/ https://www.ncbi.nlm.nih.gov/pubmed/27893429 http://dx.doi.org/10.18632/oncotarget.13526

Ejemplares similares

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
por: Sun, Kai-Xuan, et al.
Publicado: (2015)

microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
por: LI, HAO, et al.
Publicado: (2014)

MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
por: Geng, Shuo, et al.
Publicado: (2016)

Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9
por: Gong, Jian-Ping, et al.
Publicado: (2016)

Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
Publicado: (2019)

Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study
por: Wang, Yuping, et al.
Publicado: (2016)

MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells
por: Liu, Mei, et al.
Publicado: (2014)

Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin
por: Javanmardi, Sanaz, et al.
Publicado: (2020)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)

Comprehensive analysis of mRNA‐level and miRNA‐level subpathway activities for identifying robust ovarian cancer prognostic signatures
por: Tian, Songyu, et al.
Publicado: (2020)

MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2
por: Li, Li, et al.
Publicado: (2020)

MicroRNA-608 sensitizes non-small cell lung cancer cells to cisplatin by targeting TEAD2
por: Wang, Yanli, et al.
Publicado: (2019)

Regulation of ABCB1 activity by microRNA-200c and microRNA-203a in breast cancer cells: the quest for microRNAs’ involvement in cancer drug resistance
por: Armada, Ana, et al.
Publicado: (2019)

MicroRNA-654-3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells
por: Niu, Yi-Chao, et al.
Publicado: (2020)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
por: Li, Tong-tong, et al.
Publicado: (2021)

MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
por: Dahiya, Neetu, et al.
Publicado: (2008)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
por: Moghbeli, Meysam
Publicado: (2021)

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
por: Liu, Xin, et al.
Publicado: (2018)

LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
por: Miao, Jin-Tian, et al.
Publicado: (2019)

MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS
por: Zhang, Yuan, et al.
Publicado: (2018)

MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
por: Liang, Wei, et al.
Publicado: (2019)

Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin
por: Huang, Wei, et al.
Publicado: (2021)

Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2
por: Yao, Shangli, et al.
Publicado: (2021)

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein
por: Wei, Xiaoli, et al.
Publicado: (2019)

MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2
por: Li, Bo, et al.
Publicado: (2019)

microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
por: WANG, ZHONGXIAN, et al.
Publicado: (2013)

MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
por: Chen, Xin, et al.
Publicado: (2019)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis
por: Zhang, Xian, et al.
Publicado: (2015)

MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
por: Patil, Sagar L., et al.
Publicado: (2019)

microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma
por: Wang, Ziyao, et al.
Publicado: (2023)

MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy
por: Cai, Yi, et al.
Publicado: (2021)

MicroRNA‐124: An emerging therapeutic target in cancer
por: Jia, Xinqi, et al.
Publicado: (2019)

MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer
por: Quiñones-Díaz, Blanca I., et al.
Publicado: (2020)

MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers
por: Sun, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m1ejaet3t3n71eb03l8kpqjb8o